WeVote

Bill

Bill

HB 750

Community Health Center Grants for Long-Acting Reversible Contraceptives.

2025-2026 Session Introduced by Maria Cervania and 3 co-sponsors

The bill creates a recurring $2.5M/year grant program for nonprofit health centers to buy and provide FDA-approved LARCs to underserved or uninsured patients.

Passed 1st Reading
0
WeVote Research Nonpartisan
Bill Summary · HB 750

HB 750 — Community Health Center Grants for Long‑Acting Reversible Contraceptives

Status: Passed 1st Reading (filed Nov 12, 2024). Effective date specified: July 1, 2025.
Primary sponsors (NC version): Reps. Johnson‑Hostler and Clark.

Main purpose

Appropriate recurring state funds to the Department of Health and Human Services (DHHS), Division of Public Health, to create a competitive grant program for nonprofit community health centers to purchase and provide long‑acting reversible contraceptives (LARCs) to underserved, uninsured, or medically indigent patients.

Key provisions

  • Appropriation: $2,500,000 from the General Fund in recurring funds for each year of the 2025–2027 fiscal biennium.
  • Administering agency: DHHS, Division of Public Health — responsible for awarding grants on a competitive basis to nonprofit community health centers.
  • Use of funds: Grantees must spend awarded funds to purchase and make available long‑acting reversible contraceptives to eligible patients.
  • Definition of LARCs (must meet all listed criteria):
    1. Provide effective contraception for an extended period without depending on user action.
    2. Designed to be temporary and electively discontinued by the user.
    3. Approved by the U.S. Food and Drug Administration (FDA) for contraceptive use.
    4. Obtained under a prescription written by an authorized health care provider under state law.
  • Effective date: The act becomes effective July 1, 2025.

Who is affected

  • Direct recipients: Nonprofit community health centers that receive grants.
  • Beneficiaries: Underserved, uninsured, or medically indigent patients served by those centers who need contraceptive services.
  • State DHHS: Administrative responsibilities to run the grant program, establish application criteria, and oversee disbursement and compliance.
  • State budget: General Fund appropriation of $2.5 million per year for the 2025–2027 biennium.

Procedural / timeline notes

  • Introduced and advanced through committee and readings (first reading passed). Effective date set as July 1, 2025. The appropriation applies to the 2025–2027 biennium as recurring funds for each fiscal year in that period.

Potential impacts and considerations

  • Access: Expected to increase timely access to LARCs for low‑income and uninsured patients, potentially reducing unintended pregnancies.
  • Public health outcomes: May improve family‑planning outcomes and reduce downstream health and social costs associated with unintended births.
  • Cost implications: Upfront state expenditure ($2.5M/year); potential longer‑term savings to Medicaid and other programs if contraceptive access reduces unplanned pregnancies and related costs.
  • Implementation: DHHS will need administrative capacity to run competitive grant awards, monitor grantee compliance, and ensure equitable distribution to areas of highest need.

This summary reflects the bill text and fiscal/administrative structure as introduced in the North Carolina General Assembly; identical bill numbers in other jurisdictions may refer to different measures.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.